Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation Protection | 12 | 2022 | 424 | 4.000 |
Why?
|
Radiobiology | 14 | 2024 | 89 | 3.030 |
Why?
|
Bystander Effect | 13 | 2024 | 90 | 2.640 |
Why?
|
Dose-Response Relationship, Radiation | 19 | 2024 | 869 | 1.370 |
Why?
|
Health Physics | 4 | 2017 | 35 | 1.280 |
Why?
|
Radiation Dosage | 11 | 2024 | 1944 | 1.200 |
Why?
|
Chondrosarcoma | 2 | 2024 | 301 | 1.070 |
Why?
|
Fibroblasts | 12 | 2020 | 4159 | 1.040 |
Why?
|
DNA Repair | 13 | 2024 | 2048 | 1.010 |
Why?
|
Rad51 Recombinase | 5 | 2024 | 191 | 0.990 |
Why?
|
DNA Damage | 20 | 2024 | 2457 | 0.970 |
Why?
|
Dithiothreitol | 15 | 2000 | 92 | 0.940 |
Why?
|
Protons | 7 | 2020 | 1073 | 0.910 |
Why?
|
Radiation-Protective Agents | 15 | 2009 | 87 | 0.860 |
Why?
|
Radiation Tolerance | 14 | 2019 | 475 | 0.810 |
Why?
|
Sulfhydryl Compounds | 12 | 2000 | 296 | 0.770 |
Why?
|
Heavy Ions | 3 | 2019 | 11 | 0.740 |
Why?
|
Cell Survival | 22 | 2018 | 5747 | 0.670 |
Why?
|
Monte Carlo Method | 8 | 2022 | 1238 | 0.660 |
Why?
|
Radiotherapy | 3 | 2019 | 1494 | 0.610 |
Why?
|
Societies, Scientific | 2 | 2017 | 221 | 0.590 |
Why?
|
Hydrogen Peroxide | 11 | 2019 | 743 | 0.590 |
Why?
|
Glutathione | 14 | 2000 | 588 | 0.580 |
Why?
|
Radiometry | 5 | 2024 | 804 | 0.560 |
Why?
|
Radiation Injuries | 4 | 2020 | 1181 | 0.560 |
Why?
|
DNA Breaks, Double-Stranded | 7 | 2020 | 604 | 0.550 |
Why?
|
Iron | 5 | 2012 | 1816 | 0.540 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2016 | 16 | 0.530 |
Why?
|
X-Rays | 9 | 2019 | 310 | 0.510 |
Why?
|
Nuclear Medicine | 1 | 2019 | 261 | 0.490 |
Why?
|
Radiation Oncology | 3 | 2019 | 569 | 0.480 |
Why?
|
Radiation-Sensitizing Agents | 7 | 2018 | 347 | 0.460 |
Why?
|
Relative Biological Effectiveness | 6 | 2019 | 299 | 0.450 |
Why?
|
Elementary Particles | 1 | 2012 | 50 | 0.410 |
Why?
|
Laboratories | 1 | 2016 | 462 | 0.400 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.400 |
Why?
|
Radiography | 2 | 2019 | 6919 | 0.360 |
Why?
|
Linear Energy Transfer | 7 | 2020 | 147 | 0.360 |
Why?
|
Drug Tolerance | 1 | 2012 | 363 | 0.350 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1394 | 0.340 |
Why?
|
Ions | 1 | 2010 | 254 | 0.340 |
Why?
|
Film Dosimetry | 1 | 2020 | 30 | 0.330 |
Why?
|
Space Flight | 1 | 2012 | 219 | 0.330 |
Why?
|
Neoplasms | 11 | 2024 | 22340 | 0.330 |
Why?
|
Radiotherapy Dosage | 4 | 2024 | 2865 | 0.330 |
Why?
|
Extraterrestrial Environment | 1 | 2009 | 26 | 0.320 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1406 | 0.310 |
Why?
|
Apoptosis | 14 | 2019 | 9514 | 0.300 |
Why?
|
Cells | 2 | 2009 | 162 | 0.300 |
Why?
|
Weightlessness Simulation | 2 | 2018 | 41 | 0.290 |
Why?
|
Iron Isotopes | 1 | 2007 | 19 | 0.290 |
Why?
|
Micronucleus Tests | 3 | 2012 | 23 | 0.290 |
Why?
|
Signal Transduction | 10 | 2024 | 23601 | 0.290 |
Why?
|
Oxygen | 17 | 2019 | 4241 | 0.280 |
Why?
|
DNA | 12 | 2016 | 7202 | 0.280 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2007 | 36 | 0.280 |
Why?
|
Cell Line | 24 | 2011 | 15543 | 0.270 |
Why?
|
Hippocampus | 1 | 2019 | 3775 | 0.270 |
Why?
|
Histones | 5 | 2024 | 2584 | 0.270 |
Why?
|
Copper | 6 | 1997 | 367 | 0.270 |
Why?
|
Hydroxyl Radical | 6 | 1997 | 83 | 0.270 |
Why?
|
Cell Physiological Phenomena | 2 | 2018 | 148 | 0.260 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 3 | 2015 | 149 | 0.260 |
Why?
|
Ultraviolet Rays | 4 | 2019 | 1102 | 0.260 |
Why?
|
Transformation, Bacterial | 4 | 1992 | 79 | 0.250 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3278 | 0.250 |
Why?
|
DNA, Bacterial | 5 | 1992 | 1477 | 0.240 |
Why?
|
Research | 2 | 2012 | 1975 | 0.230 |
Why?
|
Bacillus subtilis | 5 | 1992 | 356 | 0.230 |
Why?
|
Cricetinae | 15 | 2003 | 2411 | 0.210 |
Why?
|
History, 21st Century | 3 | 2024 | 1574 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.210 |
Why?
|
Models, Biological | 5 | 2020 | 9443 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.200 |
Why?
|
Cell Communication | 3 | 2012 | 1660 | 0.200 |
Why?
|
Cosmic Radiation | 1 | 2022 | 24 | 0.200 |
Why?
|
Humans | 67 | 2024 | 765968 | 0.190 |
Why?
|
Superoxides | 2 | 1994 | 383 | 0.190 |
Why?
|
Nuclear Weapons | 1 | 2021 | 12 | 0.190 |
Why?
|
History, 20th Century | 3 | 2024 | 2761 | 0.190 |
Why?
|
Peroxides | 3 | 1992 | 76 | 0.190 |
Why?
|
Fumarates | 3 | 1993 | 132 | 0.180 |
Why?
|
Neurons | 2 | 2022 | 9525 | 0.180 |
Why?
|
Cell Line, Tumor | 11 | 2024 | 17075 | 0.180 |
Why?
|
Mutagenesis | 3 | 2009 | 1228 | 0.180 |
Why?
|
Kinetics | 12 | 2013 | 6274 | 0.180 |
Why?
|
Animals | 41 | 2024 | 168764 | 0.180 |
Why?
|
Catalase | 4 | 2010 | 216 | 0.170 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 543 | 0.170 |
Why?
|
Research Design | 1 | 2016 | 6209 | 0.170 |
Why?
|
Praseodymium | 1 | 2019 | 1 | 0.170 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2021 | 305 | 0.170 |
Why?
|
Osteocytes | 1 | 2021 | 193 | 0.170 |
Why?
|
Cell Death | 1 | 2005 | 1679 | 0.170 |
Why?
|
Synapsins | 1 | 2019 | 42 | 0.170 |
Why?
|
Lutetium | 1 | 2019 | 38 | 0.170 |
Why?
|
Immunotherapy | 3 | 2019 | 4752 | 0.160 |
Why?
|
Scattering, Radiation | 2 | 2020 | 482 | 0.160 |
Why?
|
Risk Assessment | 6 | 2024 | 24282 | 0.160 |
Why?
|
Free Radicals | 6 | 1997 | 238 | 0.160 |
Why?
|
Radiography, Dental | 1 | 2019 | 48 | 0.160 |
Why?
|
Cell Nucleolus | 1 | 2019 | 155 | 0.160 |
Why?
|
Stomatognathic Diseases | 1 | 2019 | 21 | 0.160 |
Why?
|
Coculture Techniques | 3 | 2012 | 1336 | 0.160 |
Why?
|
Deoxyribose | 2 | 1997 | 7 | 0.160 |
Why?
|
X-Ray Therapy | 1 | 2018 | 8 | 0.150 |
Why?
|
Computer Simulation | 4 | 2022 | 6255 | 0.150 |
Why?
|
Cricetulus | 9 | 2003 | 805 | 0.150 |
Why?
|
Gamma Rays | 6 | 2009 | 324 | 0.150 |
Why?
|
Osteoclasts | 1 | 2021 | 713 | 0.150 |
Why?
|
Cells, Cultured | 9 | 2019 | 18973 | 0.140 |
Why?
|
Caspases | 1 | 2000 | 880 | 0.140 |
Why?
|
Reactive Oxygen Species | 5 | 2010 | 2140 | 0.140 |
Why?
|
Nanoparticles | 2 | 2019 | 1964 | 0.140 |
Why?
|
Skin | 1 | 2010 | 4489 | 0.140 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2020 | 540 | 0.130 |
Why?
|
Brachytherapy | 1 | 2024 | 1222 | 0.130 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 248 | 0.130 |
Why?
|
Government Agencies | 1 | 2017 | 161 | 0.130 |
Why?
|
Phantoms, Imaging | 2 | 2020 | 2475 | 0.130 |
Why?
|
Risk | 2 | 2020 | 9591 | 0.130 |
Why?
|
Osteoblasts | 1 | 2021 | 1143 | 0.130 |
Why?
|
Particle Accelerators | 1 | 2017 | 174 | 0.130 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1430 | 0.130 |
Why?
|
Hydroxides | 2 | 1993 | 47 | 0.130 |
Why?
|
Recombinases | 1 | 2016 | 70 | 0.130 |
Why?
|
Chromosome Aberrations | 2 | 2020 | 1774 | 0.130 |
Why?
|
Parathyroid Hormone | 1 | 2021 | 1789 | 0.120 |
Why?
|
Gonorrhea | 1 | 2019 | 354 | 0.120 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 445 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2019 | 947 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2942 | 0.110 |
Why?
|
Fanconi Anemia | 3 | 2016 | 327 | 0.110 |
Why?
|
Neuropeptides | 1 | 2019 | 951 | 0.110 |
Why?
|
Osteosarcoma | 1 | 2019 | 909 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 1997 | 657 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 124 | 0.110 |
Why?
|
Chromatography | 2 | 1990 | 187 | 0.110 |
Why?
|
Endonucleases | 1 | 2016 | 372 | 0.100 |
Why?
|
Pentose Phosphate Pathway | 1 | 1993 | 125 | 0.100 |
Why?
|
Spermidine | 1 | 1992 | 63 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 811 | 0.100 |
Why?
|
Caffeine | 1 | 1997 | 702 | 0.100 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1326 | 0.100 |
Why?
|
Adaptation, Physiological | 2 | 2009 | 1308 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 720 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2880 | 0.090 |
Why?
|
Naphthyridines | 1 | 2013 | 182 | 0.090 |
Why?
|
Cations | 1 | 2011 | 240 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1874 | 0.090 |
Why?
|
Radiation, Ionizing | 3 | 2019 | 249 | 0.090 |
Why?
|
Hydroxyapatites | 1 | 1990 | 73 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2019 | 2446 | 0.090 |
Why?
|
Polyamines | 1 | 1991 | 130 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1394 | 0.090 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1643 | 0.080 |
Why?
|
Cobalt Radioisotopes | 4 | 2016 | 75 | 0.080 |
Why?
|
Deuteroporphyrins | 1 | 2009 | 8 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2020 | 2867 | 0.080 |
Why?
|
Light | 2 | 2019 | 1365 | 0.080 |
Why?
|
Benzimidazoles | 2 | 2013 | 864 | 0.080 |
Why?
|
Combined Modality Therapy | 4 | 2017 | 8529 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2090 | 0.080 |
Why?
|
Models, Statistical | 2 | 2024 | 5089 | 0.080 |
Why?
|
Rats, Inbred F344 | 1 | 2020 | 822 | 0.080 |
Why?
|
Radiation Injuries, Experimental | 1 | 1989 | 88 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2172 | 0.080 |
Why?
|
Carbon | 1 | 2012 | 677 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1153 | 0.080 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2009 | 122 | 0.070 |
Why?
|
DNA, Single-Stranded | 2 | 1990 | 353 | 0.070 |
Why?
|
Helium | 1 | 2008 | 119 | 0.070 |
Why?
|
HL-60 Cells | 2 | 2000 | 364 | 0.070 |
Why?
|
Organs at Risk | 1 | 2020 | 352 | 0.070 |
Why?
|
Computer Systems | 1 | 2009 | 466 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8041 | 0.070 |
Why?
|
Oxidation-Reduction | 5 | 2000 | 2218 | 0.070 |
Why?
|
Oxidative Stress | 4 | 2019 | 3141 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 9601 | 0.070 |
Why?
|
Mitochondria | 1 | 2000 | 3673 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2567 | 0.070 |
Why?
|
Aerobiosis | 3 | 1996 | 99 | 0.070 |
Why?
|
Catechin | 1 | 2007 | 69 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1999 | 0.070 |
Why?
|
Dithioerythritol | 1 | 1986 | 8 | 0.070 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1986 | 23 | 0.060 |
Why?
|
Vitamin E | 2 | 2009 | 869 | 0.060 |
Why?
|
Deoxy Sugars | 1 | 1985 | 17 | 0.060 |
Why?
|
Rats | 5 | 2020 | 23707 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20659 | 0.060 |
Why?
|
Glomerular Mesangium | 1 | 2005 | 98 | 0.060 |
Why?
|
Acetylcysteine | 2 | 1998 | 262 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2018 | 640 | 0.060 |
Why?
|
Technology, Radiologic | 1 | 2005 | 158 | 0.060 |
Why?
|
Mice | 9 | 2021 | 81819 | 0.060 |
Why?
|
Photosensitizing Agents | 1 | 2009 | 625 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3592 | 0.060 |
Why?
|
Time Factors | 9 | 2010 | 40065 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3916 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2659 | 0.060 |
Why?
|
G1 Phase | 1 | 2005 | 403 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2056 | 0.060 |
Why?
|
Tamoxifen | 1 | 2008 | 963 | 0.050 |
Why?
|
Reference Values | 2 | 2015 | 4908 | 0.050 |
Why?
|
History, 19th Century | 1 | 2006 | 711 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2005 | 332 | 0.050 |
Why?
|
Benchmarking | 1 | 2020 | 1052 | 0.050 |
Why?
|
Coumarins | 3 | 1997 | 120 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2796 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8611 | 0.050 |
Why?
|
Disulfides | 2 | 2000 | 462 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2010 | 1930 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6547 | 0.050 |
Why?
|
Multimedia | 1 | 2022 | 76 | 0.050 |
Why?
|
Anaerobiosis | 3 | 1988 | 140 | 0.050 |
Why?
|
Nuclear Power Plants | 1 | 2021 | 13 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8923 | 0.050 |
Why?
|
Teaching | 1 | 2009 | 1169 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3430 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2018 | 2505 | 0.050 |
Why?
|
Neutrons | 1 | 2001 | 78 | 0.050 |
Why?
|
Caspase 2 | 1 | 2000 | 26 | 0.050 |
Why?
|
Estradiol | 1 | 2008 | 1947 | 0.050 |
Why?
|
Faculty, Medical | 1 | 2009 | 1219 | 0.040 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2000 | 68 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2013 | 3584 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6113 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
Free Radical Scavengers | 2 | 1998 | 212 | 0.040 |
Why?
|
Caspase 9 | 1 | 2000 | 184 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2000 | 186 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 2000 | 238 | 0.040 |
Why?
|
Caspase 8 | 1 | 2000 | 198 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2013 | 3946 | 0.040 |
Why?
|
Lymphocytes | 1 | 2008 | 2599 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.040 |
Why?
|
Caspase 1 | 1 | 2000 | 227 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6942 | 0.040 |
Why?
|
Pyruvic Acid | 1 | 2000 | 205 | 0.040 |
Why?
|
Biology | 1 | 2021 | 293 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 761 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1870 | 0.040 |
Why?
|
United States | 5 | 2024 | 72903 | 0.040 |
Why?
|
tert-Butylhydroperoxide | 2 | 1989 | 11 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2019 | 227 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 1993 | 5783 | 0.040 |
Why?
|
DNA, Ribosomal | 1 | 2019 | 300 | 0.040 |
Why?
|
CHO Cells | 4 | 2003 | 1372 | 0.040 |
Why?
|
Caspase 3 | 1 | 2000 | 731 | 0.040 |
Why?
|
DNA Glycosylases | 1 | 2019 | 125 | 0.040 |
Why?
|
Bone Diseases, Metabolic | 1 | 2021 | 407 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 1997 | 697 | 0.040 |
Why?
|
Bone Resorption | 1 | 2021 | 717 | 0.040 |
Why?
|
Chelating Agents | 2 | 1996 | 380 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2018 | 313 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2018 | 378 | 0.040 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1997 | 45 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 1997 | 310 | 0.030 |
Why?
|
Computer Graphics | 1 | 2019 | 344 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1997 | 288 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 784 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5696 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 299 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5389 | 0.030 |
Why?
|
Cesium Radioisotopes | 1 | 2016 | 38 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1652 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1996 | 204 | 0.030 |
Why?
|
Schools, Medical | 1 | 2022 | 876 | 0.030 |
Why?
|
Chromosomes | 1 | 2019 | 578 | 0.030 |
Why?
|
Research Report | 1 | 2019 | 367 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1997 | 2477 | 0.030 |
Why?
|
Guanosine Triphosphate | 1 | 1996 | 313 | 0.030 |
Why?
|
Carcinoma | 1 | 2007 | 2312 | 0.030 |
Why?
|
Buthionine Sulfoximine | 2 | 1998 | 17 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2920 | 0.030 |
Why?
|
Oligopeptides | 1 | 2000 | 1192 | 0.030 |
Why?
|
Mercaptoethylamines | 1 | 1994 | 4 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13648 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 2016 | 165 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 592 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2015 | 13451 | 0.030 |
Why?
|
Penicillamine | 1 | 1994 | 59 | 0.030 |
Why?
|
Photons | 1 | 2018 | 572 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2019 | 10429 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 848 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 1996 | 647 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 901 | 0.030 |
Why?
|
Phthalazines | 1 | 2016 | 397 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1971 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2017 | 800 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2010 | 2627 | 0.030 |
Why?
|
Protective Agents | 1 | 2013 | 151 | 0.030 |
Why?
|
Clone Cells | 1 | 1996 | 1672 | 0.020 |
Why?
|
Lymphangiogenesis | 1 | 2013 | 171 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1994 | 10729 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2019 | 1405 | 0.020 |
Why?
|
Osteoporosis | 1 | 2021 | 1582 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 932 | 0.020 |
Why?
|
Metals | 1 | 1996 | 710 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2274 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2013 | 1140 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36532 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
Culture Media | 1 | 1993 | 890 | 0.020 |
Why?
|
Research Personnel | 1 | 2015 | 590 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2024 | 3967 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3336 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 1992 | 256 | 0.020 |
Why?
|
Child | 1 | 2019 | 80564 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1996 | 1742 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3160 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21056 | 0.020 |
Why?
|
Temperature | 1 | 1997 | 2226 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1050 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4137 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 1992 | 562 | 0.020 |
Why?
|
Methionine Sulfoximine | 1 | 1989 | 12 | 0.020 |
Why?
|
Onium Compounds | 1 | 2009 | 26 | 0.020 |
Why?
|
Mice, Inbred C3H | 2 | 2007 | 914 | 0.020 |
Why?
|
Teaching Materials | 1 | 2009 | 85 | 0.020 |
Why?
|
Internship and Residency | 1 | 2009 | 5946 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3782 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1749 | 0.020 |
Why?
|
Lung | 3 | 1994 | 10033 | 0.020 |
Why?
|
Biophysics | 1 | 2009 | 375 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1053 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7425 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3681 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11868 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1885 | 0.020 |
Why?
|
Cysteine | 2 | 1998 | 898 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 753 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5379 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3564 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
Medicare | 1 | 2024 | 6823 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14448 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4520 | 0.020 |
Why?
|
Accreditation | 1 | 2009 | 477 | 0.020 |
Why?
|
Filtration | 1 | 1986 | 224 | 0.020 |
Why?
|
Cytochrome c Group | 1 | 1986 | 123 | 0.020 |
Why?
|
Pulse Radiolysis | 1 | 1985 | 6 | 0.020 |
Why?
|
Ribosemonophosphates | 1 | 1985 | 7 | 0.020 |
Why?
|
Lasers | 1 | 1990 | 951 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5876 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7599 | 0.020 |
Why?
|
Ribose | 1 | 1985 | 63 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1052 | 0.020 |
Why?
|
Group IV Phospholipases A2 | 1 | 2005 | 58 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5881 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2549 | 0.020 |
Why?
|
Electron Transport | 1 | 1986 | 210 | 0.010 |
Why?
|
Autophagy | 1 | 2013 | 1351 | 0.010 |
Why?
|
Cysteamine | 1 | 1984 | 24 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1985 | 321 | 0.010 |
Why?
|
Phospholipases A | 1 | 2005 | 204 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3529 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2009 | 1525 | 0.010 |
Why?
|
Demography | 1 | 2009 | 1641 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2453 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2119 | 0.010 |
Why?
|
Ovary | 1 | 1988 | 956 | 0.010 |
Why?
|
Mentors | 1 | 2009 | 671 | 0.010 |
Why?
|
Female | 6 | 2024 | 396112 | 0.010 |
Why?
|
Male | 3 | 2024 | 363698 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2822 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1136 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9525 | 0.010 |
Why?
|
Electrons | 1 | 1984 | 265 | 0.010 |
Why?
|
Photochemotherapy | 1 | 2009 | 826 | 0.010 |
Why?
|
Ethanol | 2 | 1979 | 1323 | 0.010 |
Why?
|
Educational Measurement | 1 | 2009 | 1260 | 0.010 |
Why?
|
Drug Interactions | 1 | 1986 | 1417 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2513 | 0.010 |
Why?
|
Mutation | 2 | 2019 | 30198 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9296 | 0.010 |
Why?
|
Dithionitrobenzoic Acid | 1 | 2000 | 22 | 0.010 |
Why?
|
Diamide | 1 | 2000 | 18 | 0.010 |
Why?
|
Selenium Compounds | 1 | 2000 | 11 | 0.010 |
Why?
|
Carmustine | 1 | 2000 | 137 | 0.010 |
Why?
|
Thioctic Acid | 1 | 2000 | 28 | 0.010 |
Why?
|
Forecasting | 1 | 2009 | 2936 | 0.010 |
Why?
|
Arsenites | 1 | 2000 | 64 | 0.010 |
Why?
|
Cystine | 1 | 2000 | 96 | 0.010 |
Why?
|
Arsenicals | 1 | 2000 | 117 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1998 | 114 | 0.010 |
Why?
|
Escherichia coli | 1 | 1991 | 4214 | 0.010 |
Why?
|
Chromatin | 1 | 2010 | 2980 | 0.010 |
Why?
|
Butanols | 1 | 1978 | 19 | 0.010 |
Why?
|
Hydroxylation | 1 | 1997 | 139 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5743 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1978 | 166 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3956 | 0.010 |
Why?
|
Nitrogen | 1 | 1978 | 346 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2631 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15652 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1997 | 1526 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2007 | 3425 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18293 | 0.010 |
Why?
|
Pilot Projects | 1 | 2007 | 8733 | 0.010 |
Why?
|
Molecular Structure | 1 | 1997 | 1885 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18380 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11022 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20124 | 0.010 |
Why?
|
Bacteria | 1 | 1981 | 2209 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 1990 | 92 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8731 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 1990 | 293 | 0.010 |
Why?
|
Phosphorylation | 1 | 1998 | 8278 | 0.000 |
Why?
|
Thiazoles | 1 | 1990 | 1529 | 0.000 |
Why?
|
Cell Membrane | 1 | 1990 | 3634 | 0.000 |
Why?
|
Adult | 1 | 2013 | 223044 | 0.000 |
Why?
|
Middle Aged | 1 | 2009 | 223009 | 0.000 |
Why?
|